SYNJ1 also increased 1.4-folds in individuals with DS vs. young control, 2.5-folds in DS developed AD (DSAD) vs. old control, and 4.9-folds in DSAD vs. AD patients (Martin et al., 2014). The gene discussed is SYNJ1; the disease is Alzheimer disease.